Previous 10 | Next 10 |
BioLife Solutions (NASDAQ:BLFS): Q3 GAAP EPS of $0.00 beats by $0.09. Revenue of $33.8M (+199.1% Y/Y) beats by $2.21M. Press Release Raises full-year 2021 revenue guidance to $115 to $119 million ($114.53M consensus), reflecting strong demand for proprietary bio preservation media products ...
BioLife Solutions Announces Third Quarter 2021 Financial Results Total revenue up 200% over Q3 2020; organic revenue up 37% over Q3 2020 driven by 49% growth in media revenue Raises full-year 2021 revenue guidance to $115 to $119 million, reflecting strong demand for proprie...
BioLife Solutions (NASDAQ:BLFS) is scheduled to announce Q3 earnings results on Thursday, November 11th, after market close. The consensus EPS Estimate is -$0.00 (+100.0% Y/Y) and the consensus Revenue Estimate is $31.59M (+179.6% Y/Y). Over the last 2 years, BLFS has beaten EPS estimates 38%...
BioLife Solutions Announces Executive Management Changes PR Newswire BOTHELL, Wash. , Nov. 4, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (the "Company") (Nasdaq: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and ...
BioLife Solutions to Report Third Quarter 2021 Financial Results and Provide Business Update on November 11, 2021 PR Newswire BOTHELL, Wash. , Nov. 4, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduc...
Biolife Solutions Supports Biostorage Best Practices Through SciSafe's "Centers of Excellence" With New World-Class Facility in Amsterdam PR Newswire BOTHELL, Wash. , Oct. 26, 2021 /PRNewswire/ -- Biolife Solutions , Inc. (NASDAQ: BLFS), a leading supplier of...
Hardly a week passes where we don't learn of some cutting-edge research that helps us better understand our bodies and how to harness them to combat disease. The revolutionary vaccines for COVID-19 have primed society to appreciate those breakthroughs -- and they keep coming. One unsung...
BioLife Solutions Leverages Expanded Bioproduction Tools and Services Portfolio in Multipoint Engagement with Leading CAR T-Cell Developer CryoStor® Freezer Media, evo® Smart Shipper and SciSafe® Storage Services All Utilized to Support Potential Q4 US Regulatory ...
BioLife Solutions Appoints Joydeep Goswami, MBA, PhD to Board of Directors Chief Strategy and Corporate Development Officer at Illumina PR Newswire BOTHELL, Wash. , Sept. 20, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or t...
BioLife Solutions Announces CFO Retirement Roderick de Greef Concludes 20 Year Association with BioLife PR Newswire BOTHELL, Wash. , Sept. 15, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading develo...
News, Short Squeeze, Breakout and More Instantly...
BioLife Solutions Inc. Company Name:
BLFS Stock Symbol:
NASDAQ Market:
BioLife Solutions Inc. Website:
BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024 PR Newswire BOTHELL, Wash. , July 25, 2024 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction...
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouv...
BioLife Solutions Reports First Quarter 2024 Financial Results PR Newswire Cell Processing revenue increased 10% sequentially to $16.2 million GAAP gross margin of 38% and net loss of $10.2 million Non-GAAP adjusted gross margin expands ...